Discover
AVXL
Anavex Life Sciences Corp.
3.42
2 x 3.43
6 x 3.44
bid
ask
+
0.03
1.03%
12:37 PM
timesize
| Ytd | -3.79% | |
| 1y | -69.82% |
3.37
day range
3.46
2.25
52 week range
11.70
| Open | 3.40 | Prev Close | 3.39 | Low | 3.37 | High | 3.46 | Mkt Cap | 318.33M |
| Vol | 183.47K | Avg Vol | 1.25M | EPS | -0.46 | P/E | -7.47 | Forward P/E | -17.25 |
| Beta | 1.15 | Short Ratio | 10.82 | Inst. Own | 32.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-16 | 50-d Avg | 2.66 | 200-d Avg | 3.88 | 1yr Est | 35.47 |
| Income Statement | |||
| Operating Expenses | 6.78M | ||
| Research and Development Expense | 4.66M | ||
| Selling, General and Administrative Expense | 2.13M | ||
| Operating Income | -6.78M | ||
| Income Tax Expense | 18.00K | ||
| Net Income | -5.68M | ||
| Net Income Common Stock | -5.68M | ||
| Net Income Common Stock (USD) | -5.68M | ||
| Consolidated Income | -5.68M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -5.66M | ||
| Earning Before Interest & Taxes (USD) | -5.66M | ||
| Weighted Average Shares | 89.03M | ||
| Weighted Average Shares Diluted | 89.03M | ||
| Balance Sheet | |||
| Cash and Equivalents | 131.75M | ||
| Cash and Equivalents (USD) | 131.75M | ||
| Current Assets | 132.99M | ||
| Total Assets | 132.99M | ||
| Current Liabilities | 6.37M | ||
| Total Liabilities | 6.37M | ||
| Accumulated Retained Earnings (Deficit) | -388.13M | ||
| Shareholders Equity | 126.62M | ||
| Shareholders Equity (USD) | 126.62M | ||
| Deferred Revenue | 805.00K | ||
| Trade and Non-Trade Payables | 2.64M | ||
| Tax Assets | 844.00K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 36.32M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 29.17M | ||
| Issuance (Purchase) of Equity Shares | 36.32M | ||
| Net Cash Flow from Operations | -7.15M | ||
| Share Based Compensation | 1.11M | ||